CD4 and synovial sarcoma: The combination treatment of DMF and 8-MOP/UVA induced a significantly higher cell death response compared to the monotreatments in the CD4+ T cells isolated from six SS patients ex vivo (Fig. 1a) confirming the combinatory therapeutic effect of DMF and ECP.